Watch Demo

Global Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type, By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028

Global Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type, By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
  • Publish Date:November 2022

  • Number of Pages:206

  • Report ID:6374134

  • Format:PDF

  • Publisher:KBV Research

$ 3600

Summary

The Global Head And Neck Cancer Therapeutics Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 12.3% CAGR during the forecast period.

The majority of malignancies that are jointly referred to as head and neck cancers begin in the squamous cells that cover the mucosal surfaces of the head and neck. These tumors are known as head and neck squamous cell carcinomas. Head and neck malignancies can also begin in the salivary glands, muscles, sinuses, or nerves in the head and neck, however, squamous cell carcinomas are noticeably more common.

Numerous malignancies of the head and neck are curable, especially if detected early. Although eradicating cancer is the major objective of therapy, maintaining the function of the surrounding nerves, organs, and tissues is equally crucial. When planning therapy, physicians examine how treatment may influence a patient’s quality of life, including how the patient feels, looks, speaks, eats, and breathes.

Surgical intervention, radiation treatment, chemotherapy, targeted therapy, and immunotherapy are the primary cancer treatments. Surgical procedures or radiation therapy alone, or a mix of the two, may be included in the treatment plan. The behavior of a specific head-neck cancer relies on its origin place (the primary site).

For instance, tumors that develop in the vocal cords behave quite differently from those that begin in the backside of the tongue, which is just an inch or less away from the vocal cords. Squamous cell carcinoma, which comes from the cells that cover the interior of the nose, mouth, and throat, is the most prevalent kind of cancer of the head and neck.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the care of different types of Head and neck cancer patients, having a greater impact on older patients, individuals operated primarily surgically, and those with fewer comorbidities. These individuals may experience poorer oncological outcomes due to missing or delayed diagnosis. Due to the COVID-19 pandemic, several cancer tests have been delayed or rescheduled, leaving a substantial number of people without access to required healthcare treatments. This interruption to cancer screening programs may have substantial consequences for patients, medical professionals, and health systems.

Market Growth Factors

Increasing Demand For Immunotherapy Treatment

Immunotherapy is an innovative treatment for cancer, including head and neck, lymphoma, melanoma, and non-small cell lung cancer. Some tumors respond well to conventional therapies such as chemotherapy. In other instances, immunotherapy is combined with conventional cancer therapies to increase the body’s natural defenses against cancer. As part of its regular functionality, the immune system discovers and eliminates aberrant cells, so preventing or stifling the formation of several malignancies. Immune cells, for instance, are occasionally seen in and surrounding tumors.

Increasing Patient Population To Drive Market Growth

Head and neck cancers are classified according to their location. These regions include the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity, as well as the salivary glands. An increase in alcohol and cigarette intake is a key cause of head and neck cancer. An estimated 75% of head and neck cancers are caused by alcohol and cigarette intake. Cancer will be the top cause of mortality, accounting for over 10 million fatalities, or one in six deaths.

Market Restraining Factors

Associated Side Effects Of Chemotherapy

Cancer of the head and neck are frequently treated with a mix of radiation and chemotherapy treatment. The adverse effects include hair loss, speech impairment, and loss of natural voice. In addition, after undergoing cancer surgery, people have difficulty eating. Although hair loss is a frequent side effect of chemotherapy, it does not affect everyone. Individuals can ask their care provider whether it is likely a medication side effect.

Therapy Type Outlook

Based on the Therapy Type, the Head and Neck Cancer Therapeutics Market is segmented into Chemotherapy, Immunotherapy, and Targeted Therapy. The immunotherapy segment acquired the highest revenue share in the head and neck therapeutics market in 2021. It is because immunotherapy make use of the immune system to treat cancer. Pembrolizumab, an anti-PD1 immunotherapy that targets cells with a deficiency in their capacity to repair DNA, may fall under this category.

Route of Administration Outlook

On the basis of the Route of Administration, the Head and Neck Cancer Therapeutics Market is divided into Injectable and Oral. The oral segment garnered a substantial revenue share in the head and neck cancer therapeutics market in 2021. Due to the rising number of oral medicinal medicines used to treat patients with Head and neck cancer. It is anticipated that the successful conclusion of the study and subsequent launch will stimulate segment growth. Patients with cancer are also administered oral chemotherapy.

Distribution Channel Outlook

By Distribution Channel, the Head and Neck Cancer Therapeutics Market is classified into Retail and Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies. The retail and specialty pharmacies witnessed the highest segment revenue share in the head and neck cancer therapeutics market in 2021. It is because specialty pharmacies offer medications unavailable in conventional pharmacies, such as immunotherapy drugs. Providing these drugs through a specialty pharmacy guarantees their appropriate and secure delivery.

Regional Outlook

Region-wise, the Head and Neck Cancer Therapeutics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment registered the largest revenue share in the head and neck cancer therapeutics market in 2021. It is due to the government assistance for the expansion of the healthcare sector, attractive reimbursement rules, a high level of illness awareness, and easy access to high-quality healthcare facilities are among the factors that have contributed to the expansion of the regional market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.

Strategies Deployed in Head And Neck Cancer Therapeutics Market

Aug-2022: Sanofi came into collaboration with Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures, and commercializes medicines for cancer treatment. Through this collaboration, the company aims to accelerate the development and future commercialization of oncology medicines as well as strengthen its presence in oncology in China.

Jul-2022: AstraZeneca completed the acquisition of TeneoTwo, comprising obtaining the rights to TNB-486, a BiTE currently in Phase I for R/R B-cell non-Hodgkin lymphoma. With this acquisition, the company broadened its hematology portfolio.

Feb-2022: Sanofi took over Amunix Pharmaceuticals, an immuno-oncology company. Through this acquisition, the company gets access to Amunix XPAC technology, Pro-XTEN, and XPAT which complement the company’s existing R&D platform that further helps in accelerating and expanding innovative oncology medicines. Through this acquisition, Sanofi enhances its immuno-oncology portfolio by adding Amunix’s promising pipeline.

Mar-2021: Takeda Pharmaceutical Company Limited came into an agreement to acquire Maverick Therapeutics, Inc., a private biopharmaceutical company developing conditionally active bispecific T-cell targeted immunotherapies. With this acquisition, the company would expand its Immuno-Oncology Portfolio with Maverick’s Conditionally Active Bispecific T-cell Engagers COBRA Platform, which is designed to Target Solid Tumors.

Nov-2020: Merck (MSD) came into an agreement to acquire all outstanding shares of VelosBio, a portfolio company of Pappas Capital. Through this acquisition, Merck will strengthen its oncology pipeline with the addition of VLS-101, VelosBio’s lead investigational candidate.

Sep-2020: Takeda Pharmaceutical opened a new R&D headquarters in Boston, Massachusetts. The new facility focuses on enhancing the development and end-to-end research capabilities of the company to develop cell therapies with the potential to expand into other therapeutic areas.

Aug-2020: Teva Pharmaceutical Industries joined hands with Alvotech, a combined biopharmaceutical company. Through this collaboration, Alvotech would allow Teva to access its technical expertise in working with the FDA to bring products to the U.S. market while enlarging its growing biosimilar offering and utilizing its unique cross-functional expertise throughout both generic and specialty medicines.

Oct-2018: AstraZeneca and MedImmune, the research and development division expanded its existing collaboration with Innate Pharma (Innate), a biotech company, that focuses on clinical-stage oncology. Through this collaboration, both companies are looking forward to innovate new medicines which accelerate their oncology portfolio.

Feb-2018: Bristol-Myers Squibb teamed up with Nektar Therapeutics, the global biopharmaceutical company. Through this collaboration, the companies would jointly create and market NKTR-214 in integration with Bristol-Myers Squibb’s Opdivo and Opdivo plus Yervoy in more than 20 presentations across 9 tumor types, along with potential mixtures with other anti-cancer representatives from either of the individual businesses and/or third parties.

Scope of the Study

Market Segments covered in the Report:

By Therapy Type

• Immunotherapy

• Chemotherapy

• Targeted Therapy

By Route of Administration

• Injectable

• Oral

By Distribution Channel

• Retail & Specialty Pharmacies

• Hospital Pharmacies

• Online Pharmacies

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Eli Lilly and Company

• Merck & Co., Inc.

• Sanofi S.A.

• Takeda Pharmaceutical Company Limited

• Teva Pharmaceuticals Industries Ltd.

• F. Hoffmann-La Roche Ltd.

• AstraZeneca Plc

• Bristol Myers Squibb Company

• Clinigen Group PLC

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Table of contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Head & Neck Cancer Therapeutics Market, by Therapy Type
1.4.2 Global Head & Neck Cancer Therapeutics Market, by Route of Administration
1.4.3 Global Head & Neck Cancer Therapeutics Market, by Distribution Channel
1.4.4 Global Head & Neck Cancer Therapeutics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Head And Neck Cancer Therapeutics Market

Chapter 4. Global Head & Neck Cancer Therapeutics Market by Therapy Type
4.1 Global Immunotherapy Market by Region
4.2 Global Chemotherapy Market by Region
4.3 Global Targeted Therapy Market by Region

Chapter 5. Global Head & Neck Cancer Therapeutics Market by Route of Administration
5.1 Global Injectable Market by Region
5.2 Global Oral Market by Region

Chapter 6. Global Head & Neck Cancer Therapeutics Market by Distribution Channel
6.1 Global Retail & Specialty Pharmacies Market by Region
6.2 Global Hospital Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Head & Neck Cancer Therapeutics Market by Region
7.1 North America Head & Neck Cancer Therapeutics Market
7.1.1 North America Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.1.1 North America Immunotherapy Market by Country
7.1.1.2 North America Chemotherapy Market by Country
7.1.1.3 North America Targeted Therapy Market by Country
7.1.2 North America Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.2.1 North America Injectable Market by Country
7.1.2.2 North America Oral Market by Country
7.1.3 North America Head & Neck Cancer Therapeutics Market by Distribution Channel
7.1.3.1 North America Retail & Specialty Pharmacies Market by Country
7.1.3.2 North America Hospital Pharmacies Market by Country
7.1.3.3 North America Online Pharmacies Market by Country
7.1.4 North America Head & Neck Cancer Therapeutics Market by Country
7.1.4.1 US Head & Neck Cancer Therapeutics Market
7.1.4.1.1 US Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.4.1.2 US Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.4.1.3 US Head & Neck Cancer Therapeutics Market by Distribution Channel
7.1.4.2 Canada Head & Neck Cancer Therapeutics Market
7.1.4.2.1 Canada Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.4.2.2 Canada Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.4.2.3 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel
7.1.4.3 Mexico Head & Neck Cancer Therapeutics Market
7.1.4.3.1 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.4.3.2 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.4.3.3 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel
7.1.4.4 Rest of North America Head & Neck Cancer Therapeutics Market
7.1.4.4.1 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.4.4.2 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.4.4.3 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2 Europe Head & Neck Cancer Therapeutics Market
7.2.1 Europe Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.1.1 Europe Immunotherapy Market by Country
7.2.1.2 Europe Chemotherapy Market by Country
7.2.1.3 Europe Targeted Therapy Market by Country
7.2.2 Europe Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.2.1 Europe Injectable Market by Country
7.2.2.2 Europe Oral Market by Country
7.2.3 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.3.1 Europe Retail & Specialty Pharmacies Market by Country
7.2.3.2 Europe Hospital Pharmacies Market by Country
7.2.3.3 Europe Online Pharmacies Market by Country
7.2.4 Europe Head & Neck Cancer Therapeutics Market by Country
7.2.4.1 Germany Head & Neck Cancer Therapeutics Market
7.2.4.1.1 Germany Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.1.2 Germany Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.1.3 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.4.2 UK Head & Neck Cancer Therapeutics Market
7.2.4.2.1 UK Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.2.2 UK Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.2.3 UK Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.4.3 France Head & Neck Cancer Therapeutics Market
7.2.4.3.1 France Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.3.2 France Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.3.3 France Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.4.4 Russia Head & Neck Cancer Therapeutics Market
7.2.4.4.1 Russia Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.4.2 Russia Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.4.3 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.4.5 Spain Head & Neck Cancer Therapeutics Market
7.2.4.5.1 Spain Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.5.2 Spain Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.5.3 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.4.6 Italy Head & Neck Cancer Therapeutics Market
7.2.4.6.1 Italy Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.6.2 Italy Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.6.3 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2.4.7 Rest of Europe Head & Neck Cancer Therapeutics Market
7.2.4.7.1 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.4.7.2 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.4.7.3 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3 Asia Pacific Head & Neck Cancer Therapeutics Market
7.3.1 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.1.1 Asia Pacific Immunotherapy Market by Country
7.3.1.2 Asia Pacific Chemotherapy Market by Country
7.3.1.3 Asia Pacific Targeted Therapy Market by Country
7.3.2 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.2.1 Asia Pacific Injectable Market by Country
7.3.2.2 Asia Pacific Oral Market by Country
7.3.3 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.3.1 Asia Pacific Retail & Specialty Pharmacies Market by Country
7.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
7.3.3.3 Asia Pacific Online Pharmacies Market by Country
7.3.4 Asia Pacific Head & Neck Cancer Therapeutics Market by Country
7.3.4.1 China Head & Neck Cancer Therapeutics Market
7.3.4.1.1 China Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.1.2 China Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.1.3 China Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.4.2 Japan Head & Neck Cancer Therapeutics Market
7.3.4.2.1 Japan Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.2.2 Japan Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.2.3 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.4.3 India Head & Neck Cancer Therapeutics Market
7.3.4.3.1 India Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.3.2 India Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.3.3 India Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.4.4 South Korea Head & Neck Cancer Therapeutics Market
7.3.4.4.1 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.4.2 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.4.3 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.4.5 Singapore Head & Neck Cancer Therapeutics Market
7.3.4.5.1 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.5.2 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.5.3 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.4.6 Malaysia Head & Neck Cancer Therapeutics Market
7.3.4.6.1 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.6.2 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.6.3 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market
7.3.4.7.1 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.4.7.2 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.4.7.3 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4 LAMEA Head & Neck Cancer Therapeutics Market
7.4.1 LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.1.1 LAMEA Immunotherapy Market by Country
7.4.1.2 LAMEA Chemotherapy Market by Country
7.4.1.3 LAMEA Targeted Therapy Market by Country
7.4.2 LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.2.1 LAMEA Injectable Market by Country
7.4.2.2 LAMEA Oral Market by Country
7.4.3 LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.3.1 LAMEA Retail & Specialty Pharmacies Market by Country
7.4.3.2 LAMEA Hospital Pharmacies Market by Country
7.4.3.3 LAMEA Online Pharmacies Market by Country
7.4.4 LAMEA Head & Neck Cancer Therapeutics Market by Country
7.4.4.1 Brazil Head & Neck Cancer Therapeutics Market
7.4.4.1.1 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.1.2 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.1.3 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.4.2 Argentina Head & Neck Cancer Therapeutics Market
7.4.4.2.1 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.2.2 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.2.3 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.4.3 UAE Head & Neck Cancer Therapeutics Market
7.4.4.3.1 UAE Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.3.2 UAE Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.3.3 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.4.4 Saudi Arabia Head & Neck Cancer Therapeutics Market
7.4.4.4.1 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.4.2 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.4.3 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.4.5 South Africa Head & Neck Cancer Therapeutics Market
7.4.4.5.1 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.5.2 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.5.3 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.4.6 Nigeria Head & Neck Cancer Therapeutics Market
7.4.4.6.1 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.6.2 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.6.3 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4.4.7 Rest of LAMEA Head & Neck Cancer Therapeutics Market
7.4.4.7.1 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.4.7.2 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.4.7.3 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.2 Merck & Co., Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Takeda Pharmaceutical Company Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Bristol Myers Squibb Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Clinigen Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis

List of Tables
TABLE 1 Global Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Global Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Global Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 4 Global Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 5 Global Immunotherapy Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Immunotherapy Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Chemotherapy Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Chemotherapy Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Targeted Therapy Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Targeted Therapy Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 Global Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 Global Injectable Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Injectable Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Oral Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Oral Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 Global Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 Global Retail & Specialty Pharmacies Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Retail & Specialty Pharmacies Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Online Pharmacies Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Online Pharmacies Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Head & Neck Cancer Therapeutics Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Head & Neck Cancer Therapeutics Market by Region, 2022 - 2028, USD Million
TABLE 27 North America Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 North America Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 North America Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 38 North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 39 North America Injectable Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Injectable Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 North America Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 53 US Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 54 US Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 55 US Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 56 US Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 57 US Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 US Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 US Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 US Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Canada Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 62 Canada Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 63 Canada Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 64 Canada Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 65 Canada Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 Canada Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Mexico Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 70 Mexico Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 71 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 72 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 73 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Rest of North America Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 78 Rest of North America Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 79 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 80 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 81 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Europe Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 86 Europe Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 87 Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 88 Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 89 Europe Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 90 Europe Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 91 Europe Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 92 Europe Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 93 Europe Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 94 Europe Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 95 Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 96 Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 97 Europe Injectable Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Injectable Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 100 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 101 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 102 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 103 Europe Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 105 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 111 Germany Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 112 Germany Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 113 Germany Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 114 Germany Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 115 Germany Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 116 Germany Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 117 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 118 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 119 UK Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 120 UK Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 121 UK Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 122 UK Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 123 UK Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 124 UK Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 125 UK Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 126 UK Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 127 France Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 128 France Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 129 France Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 130 France Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 131 France Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 132 France Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 133 France Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 134 France Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 135 Russia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 136 Russia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 137 Russia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 138 Russia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 139 Russia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 140 Russia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 141 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 142 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 143 Spain Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 144 Spain Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 145 Spain Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 146 Spain Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 147 Spain Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 148 Spain Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 149 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 150 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 151 Italy Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 152 Italy Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 153 Italy Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 154 Italy Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 155 Italy Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 156 Italy Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 157 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 158 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 159 Rest of Europe Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 160 Rest of Europe Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 161 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 162 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 163 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 164 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 165 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 166 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 167 Asia Pacific Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 168 Asia Pacific Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 169 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 170 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 171 Asia Pacific Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 172 Asia Pacific Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 173 Asia Pacific Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 174 Asia Pacific Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 175 Asia Pacific Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 176 Asia Pacific Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 177 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 178 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.